# Virological Suppression in HIV Positive Patients Involved in a Novel Standardized Adherence Protocol

> **NCT03517358** · PHASE3 · COMPLETED · sponsor: **University of California, Davis** · enrollment: 10 (actual)

## Conditions studied

- Hiv

## Interventions

- **OTHER:** Service of care

## Key facts

- **NCT ID:** NCT03517358
- **Lead sponsor:** University of California, Davis
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-01
- **Primary completion:** 2018-05-01
- **Final completion:** 2018-05-01
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2020-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03517358

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03517358, "Virological Suppression in HIV Positive Patients Involved in a Novel Standardized Adherence Protocol". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03517358. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*